In the depths of an Australian winter, Lumos Diagnostics Holdings gathered its investors — some in rooms, some across time zones — to account for a quarter's worth of work in the diagnostic sector. CEO Doug Ward and CFO Barrie Lambert led a formal earnings briefing on July 28, 2026, while simultaneously conducting in-person roadshows across Melbourne and Sydney, a dual performance that speaks to the enduring human need to be seen and heard when numbers alone may not be enough. The choice to place leadership physically among shareholders, rather than behind a screen, is itself a kind of stateme